Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s innovative drug development initiative-Group 3 pulmonary hypertension

By sjmartinez • July 1, 2022

Nikkho SM, Richter MJ, Shen E, Abman SH, Antoniou K, Chung J, Fernandes P, Hassoun P, Lazarus HM, Olschewski H, Piccari L, Psotka M, Saggar R, Shlobin OA, Stockbridge N, Vitulo P, Vizza CD, Wort SJ, Nathan SD. Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension. Pulm Circ. 2022 Jul 1;12(3):e12127. doi: 10.1002/pul2.12127. PMID: 36016668; PMCID: PMC9395696.

Tags: Epidemiology, interstitial lung disease, prognosis, Publications, pulmonary hypertension, Pulmonary, Critical Care & Sleep Medicine, symptom assessment and management

Clinical Practice Guideline for Evaluation and Management of Peripheral Nervous System Manifestations in Sjögren’s Disease

Deboo A, Fox R, Hammitt KM, Frantsve-Hawley J, Baker MC, Danielides S, De Sousa E, Goodman BP, King JK, Mandel S, Noaiseh G, Pavlakis PP,[...]

Implementing novel tools for enhancing diagnostic and therapeutic capacities to promote global public health and outcomes in kidney disease management and transplantation

Tantisattamo E, Hanna RM, Kalantar-Zadeh K. Implementing novel tools for enhancing diagnostic and therapeutic capacities to promote global public health and outcomes in kidney disease[...]

Unraveling the Complexity: A Case of Systemic Lupus Erythematosus, Warm Autoimmune Hemolytic Anemia, and Autoimmune Cholangitis

Sharma R, Dao KT, Garcia-Corella J, Dhillon H, Kalha I, Kim S, Stull WR, Petersen G. Unraveling the Complexity: A Case of Systemic Lupus Erythematosus,[...]